Cartesian Therapeutics (RNAC) Current Deferred Revenue (2015 - 2024)
Cartesian Therapeutics' Current Deferred Revenue was $412,000 in Q1 2024, down 90.3% from $4.23 million a year earlier and down 82.2% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Current Deferred Revenue (2015 - 2024) Analysis & Trends
At the end of FY2023, Current Deferred Revenue at Cartesian Therapeutics came in at $2.31 million, up 289.7% from FY2022.
- Current Deferred Revenue shows a five-year compound annual growth rate of 19.2% (FY2018 to FY2023).
- In earlier years, Current Deferred Revenue was $593,000 in FY2022 (-98.9%), $53.88 million in FY2021 (-25.2%), $72.05 million in FY2020 and $1.67 million in FY2019 (+74.6%).
- The Q1 2024 figure marks the lowest quarterly Current Deferred Revenue in data going back to Q4 2015.
- Compared with a year earlier, Current Deferred Revenue was higher in two of the last eight quarters, with an average decline of 27.8%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q4 2023 (growth of 289.7%); the worst was Q4 2022 (a decline of 98.9%).
- Per Business Quant data, RNAC's Current Deferred Revenue in the three quarters before Q1 2024 was $2.31 million (Q4 2023), $4.14 million (Q3 2023) and $4.23 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Cartesian Therapeutics | 217.47 Mn | 217.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 412,000.00 |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 4.14 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 4.23 Mn |
| Dec 31, 2022 | 593,000.00 |
| Sep 30, 2022 | 3.82 Mn |
| Jun 30, 2022 | 15.97 Mn |
| Mar 31, 2022 | 27.99 Mn |
| Dec 31, 2021 | 53.88 Mn |
| Sep 30, 2021 | 62.32 Mn |
| Jun 30, 2021 | 75.01 Mn |
| Mar 31, 2021 | 75.76 Mn |
| Dec 31, 2020 | 72.05 Mn |
| Sep 30, 2020 | 64.37 Mn |
| Jun 30, 2020 | 1.93 Mn |
| Mar 31, 2020 | 1.67 Mn |
| Dec 31, 2019 | 1.67 Mn |
| Sep 30, 2019 | 1.02 Mn |
| Jun 30, 2019 | 1.02 Mn |
API Access
Cartesian Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();